drugset / Trial / NCT00544258

Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

NCT00544258

Phase 1 Completed 8 enrolled Peplin
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the extent of systemic absorption of PEP005 when applied topically for the treatment of actinic keratoses.

Timeline

Start
2007-10
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject ingenol mebutate Small molecule 0.05 % Topical

Indications